SCHEMBL7757254

SCHEMBL7757254

NCCCC[C@H](NOC(=C=O)c1ccccc1)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
ANPEP P15144 1/20 0.39
TLR2 O60603 2/20 0.39
FOLH1 Q04609 1/20 0.39
CPB2 Q96IY4 2/20 0.39
PLG P00747 1/20 0.39
CTSB P07858 1/20 0.38
ERAP2 Q6P179 2/20 0.38
LNPEP Q9UIQ6 2/20 0.38
ERAP1 Q9NZ08 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
ECE1 P42892 1/20 0.37
CPB1 P15086 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8645817 0.75 MMP2 (0.47) MMP2MMP9ANPEPTLR2FOLH1
SCHEMBL607886 0.74 ITGB3 (0.60) MMP2MMP9ITGB3ITGA2BFOLH1
SCHEMBL607885 0.74 ITGB3 (0.60) MMP2MMP9ITGB3ITGA2BFOLH1
SCHEMBL7226853 0.73 MMP2 (0.50) MMP2MMP9ITGB3ITGA2BANPEP
SCHEMBL29005745 0.73 MMP2 (0.50) MMP2MMP9ANPEPTLR2FOLH1
SCHEMBL7226850 0.73 MMP2 (0.50) MMP2MMP9ITGB3ITGA2BANPEP
SCHEMBL30257380 0.72 FOLH1 (0.53) MMP2MMP9FOLH1CPB2CA1
SCHEMBL6152839 0.72 MMP2 (0.49) MMP2MMP9ITGB3ITGA2BANPEP
SCHEMBL5840489 0.72 MMP2 (0.49) MMP2MMP9ITGB3ITGA2BANPEP
Methane SCHEMBL28261132 0.72 MMP2 (0.49) MMP2MMP9ITGB3ITGA2BANPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077995-A1 ANTIANGIOGENIC DRUG TO TREAT CANCER, ARTHRITIS AND RETINOPATHY ABBOTT LABORATORIES (US) 2001-02-28 EP disclosed
WO-1999061466-A1 ANTIANGIOGENIC DRUG TO TREAT CANCER, ARTHRITIS AND RETINOPATHY ABBOTT LABORATORIES (US) 1999-12-02 WO disclosed